Theriva Biologics

(NYSEMKT) TOVX

Current Price$0.31

Market Cap$14.41M

Since IPO (2006)-100%

5 Year-100%

1 Year-32%

1 Month-16%

Theriva Biologics Financials at a Glance

Market Cap

$14.41M

Revenue (TTM)

$300.00K

Net Income (TTM)

$21.46M

EPS (TTM)

$-2.53

P/E Ratio

-0.12

Dividend

$0.00

Beta (Volatility)

0.92 (Low)

Dividend

$0.00

Beta (Volatility)

0.92 (Low)

Price

$0.31

Volume

1,298,933

Open

$0.29

Price

$0.31

Volume

1,298,933

Open

$0.29

Previous Close

$0.31

Daily Range

$0.29 - $0.31

52-Week Range

$0.16 - $0.86

Dividend

$0.00

Beta (Volatility)

0.92 (Low)

Price

$0.31

Volume

1,298,933

Open

$0.29

Previous Close

$0.31

Daily Range

$0.29 - $0.31

52-Week Range

$0.16 - $0.86

TOVX News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Theriva Biologics

Industry

Biotechnology

Sector

Health Care

Employees

CEO

Steven A. Shallcross, MBA, CPA

Website

www.therivabio.com

Headquarters

Rockville, MD 20850, US

TOVX Financials

Key Financial Metrics (TTM)

Gross Margin

92%

Operating Margin

-72%

Net Income Margin

-72%

Return on Equity

-139%

Return on Capital

-78%

Return on Assets

-56%

Earnings Yield

-8.33%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$14.41M

Shares Outstanding

45.89M

Volume

1.30M

Avg. Volume

20.98M

Financials (TTM)

Gross Profit

$108.00K

Operating Income

$15.02M

EBITDA

$14.91M

Operating Cash Flow

$16.67M

Capital Expenditure

$35.00K

Free Cash Flow

$16.70M

Cash & ST Invst.

$13.06M

Total Debt

$2.63M

Theriva Biologics Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q1 2026YOY CHG

Revenue

$300.00K

N/A

Gross Profit

$276.00K

N/A

Gross Margin

92.00%

N/A

Market Cap

$14.41M

N/A

Market Cap/Employee

$720.51K

N/A

Employees

N/A

Net Income

$2.04M

+52.7%

EBITDA

$2.08M

+52.5%

Quarterly Fundamentals

Name

Q1 2026YOY CHG

Net Cash

$12.36M

+72.7%

Accounts Receivable

$0.00

-100.0%

Inventory

$0.00

N/A

Long Term Debt

$1.52M

-31.9%

Short Term Debt

$545.00K

-12.0%

Return on Assets

-56.10%

N/A

Return on Invested Capital

-77.67%

N/A

Free Cash Flow

$2.46M

+48.4%

Operating Cash Flow

$2.46M

+48.4%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

CMMBChemomab Therapeutics Ltd.

CMMBChemomab Therapeutics Ltd.$2.02+9.37%

BIVIBioVie Inc.

BIVIBioVie Inc.$1.52+2.70%

NKGNNKGen Biotech, Inc. Common Stock

NKGNNKGen Biotech, Inc. Common Stock$0.06+0.00%

MLECMoolec Science S.A.

MLECMoolec Science S.A.$7.77+5.51%

ELABPMGC Holdings Inc.

ELABPMGC Holdings Inc.$1.78+7.23%

GLMDGalmed Pharmaceuticals Ltd.

GLMDGalmed Pharmaceuticals Ltd.$0.58-3.32%

ISPCiSpecimen Inc.

ISPCiSpecimen Inc.$3.45-3.36%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

NOKNokia

NOKNokia$15.47+0.09%

FFord Motor Company

FFord Motor Company$14.93+0.09%

AALAmerican Airlines Group

AALAmerican Airlines Group$13.85+0.02%

NIONio

NIONio$5.20-0.07%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$15.26+0.04%

QUBTQuantum Computing

QUBTQuantum Computing$12.31+0.08%

INFQInfleqtion

INFQInfleqtion $16.35+0.11%

Questions About TOVX

What is the current price of Theriva Biologics?

Theriva Biologics is trading at $0.31 per share.

What is the 52-week range for Theriva Biologics?

Over the past 52 weeks, Theriva Biologics has traded between $0.16 and $0.86.

How much debt does Theriva Biologics have?

As of the most recent reporting period, Theriva Biologics reported total debt of $3.69M.

How much cash does Theriva Biologics have on hand?

Theriva Biologics reported $14.43M in cash and cash equivalents in its most recent financial results.

What is Theriva Biologics’s dividend yield?

Theriva Biologics does not currently have a dividend yield.

Theriva Biologics

Theriva Biologics Financials at a Glance

TOVX News

1 Biotech Soars While Another Crashes

Is Coach a Rule Breaker?

eBay Made Easy

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Theriva Biologics

TOVX Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Theriva Biologics Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About TOVX

What is the current price of Theriva Biologics?

What is the 52-week range for Theriva Biologics?

How much debt does Theriva Biologics have?

How much cash does Theriva Biologics have on hand?

What is Theriva Biologics’s dividend yield?

Premium Investing Services